Review
doi: 10.1038/nrd2614.Nanoparticle therapeutics: an emerging treatment modality for cancer
Affiliations
- PMID:18758474
- DOI: 10.1038/nrd2614
Item in Clipboard
Review
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E Davis et al. Nat Rev Drug Discov.2008 Sep.
Display options
Format
Display options
Format
Abstract
Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.
Similar articles
- Active targeting schemes for nanoparticle systems in cancer therapeutics.Byrne JD, Betancourt T, Brannon-Peppas L.Byrne JD, et al.Adv Drug Deliv Rev. 2008 Dec 14;60(15):1615-26. doi: 10.1016/j.addr.2008.08.005. Epub 2008 Sep 20.Adv Drug Deliv Rev. 2008.PMID:18840489Review.
- Nanoparticle technologies for cancer therapy.Alexis F, Pridgen EM, Langer R, Farokhzad OC.Alexis F, et al.Handb Exp Pharmacol. 2010;(197):55-86. doi: 10.1007/978-3-642-00477-3_2.Handb Exp Pharmacol. 2010.PMID:20217526Review.
- Nanoparticle and targeted systems for cancer therapy.Brannon-Peppas L, Blanchette JO.Brannon-Peppas L, et al.Adv Drug Deliv Rev. 2004 Sep 22;56(11):1649-59. doi: 10.1016/j.addr.2004.02.014.Adv Drug Deliv Rev. 2004.PMID:15350294Review.
- The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo.Ng HL, Lu A, Lin G, Qin L, Yang Z.Ng HL, et al.Int J Mol Sci. 2014 Dec 24;16(1):230-55. doi: 10.3390/ijms16010230.Int J Mol Sci. 2014.PMID:25547490Free PMC article.Review.
- Composite nanoparticles take aim at cancer.Gil PR, Parak WJ.Gil PR, et al.ACS Nano. 2008 Nov 25;2(11):2200-5. doi: 10.1021/nn800716j.ACS Nano. 2008.PMID:19206383Review.
Cited by
- On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles.Lee JH, Chen KJ, Noh SH, Garcia MA, Wang H, Lin WY, Jeong H, Kong BJ, Stout DB, Cheon J, Tseng HR.Lee JH, et al.Angew Chem Int Ed Engl. 2013 Apr 15;52(16):4384-4388. doi: 10.1002/anie.201207721. Epub 2013 Mar 20.Angew Chem Int Ed Engl. 2013.PMID:23519915Free PMC article.No abstract available.
- Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.Cely I, Yiv S, Yin Q, Shahidzadeh A, Tang L, Cheng J, Uckun FM.Cely I, et al.J Anal Oncol. 2012 Jun 25;1(1):1-9. doi: 10.6000/1927-7229.2012.01.01.1.J Anal Oncol. 2012.PMID:23730399Free PMC article.
- Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: evidence of a beneficial effect on myoblast fusion.Poussard S, Decossas M, Le Bihan O, Mornet S, Naudin G, Lambert O.Poussard S, et al.Int J Nanomedicine. 2015 Feb 19;10:1479-92. doi: 10.2147/IJN.S74158. eCollection 2015.Int J Nanomedicine. 2015.PMID:25733836Free PMC article.
- RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation.Li H, Rychahou PG, Cui Z, Pi F, Evers BM, Shu D, Guo P, Luo W.Li H, et al.Nucleic Acid Ther. 2015 Aug;25(4):188-97. doi: 10.1089/nat.2014.0525. Epub 2015 May 27.Nucleic Acid Ther. 2015.PMID:26017686Free PMC article.
- Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch.He W, Yan J, Jiang W, Li S, Qu Y, Niu F, Yan Y, Sui F, Wang S, Zhou Y, Jin L, Li Y, Ji M, Ma PX, Liu M, Lu W, Hou P.He W, et al.Chem Mater. 2018;30(20):7034-7046. doi: 10.1021/acs.chemmater.8b02572. Epub 2018 Sep 21.Chem Mater. 2018.PMID:32982042Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources